These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21596231)

  • 1. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.
    McNair WP; Sinagra G; Taylor MR; Di Lenarda A; Ferguson DA; Salcedo EE; Slavov D; Zhu X; Caldwell JH; Mestroni L;
    J Am Coll Cardiol; 2011 May; 57(21):2160-8. PubMed ID: 21596231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A proton leak current through the cardiac sodium channel is linked to mixed arrhythmia and the dilated cardiomyopathy phenotype.
    Gosselin-Badaroudine P; Keller DI; Huang H; Pouliot V; Chatelier A; Osswald S; Brink M; Chahine M
    PLoS One; 2012; 7(5):e38331. PubMed ID: 22675453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation.
    Olson TM; Michels VV; Ballew JD; Reyna SP; Karst ML; Herron KJ; Horton SC; Rodeheffer RJ; Anderson JL
    JAMA; 2005 Jan; 293(4):447-54. PubMed ID: 15671429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmic Phenotypes Are a Defining Feature of Dilated Cardiomyopathy-Associated
    Peters S; Thompson BA; Perrin M; James P; Zentner D; Kalman JM; Vandenberg JI; Fatkin D
    Circ Genom Precis Med; 2022 Feb; 15(1):e003432. PubMed ID: 34949099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R222Q SCN5A mutation is associated with reversible ventricular ectopy and dilated cardiomyopathy.
    Mann SA; Castro ML; Ohanian M; Guo G; Zodgekar P; Sheu A; Stockhammer K; Thompson T; Playford D; Subbiah R; Kuchar D; Aggarwal A; Vandenberg JI; Fatkin D
    J Am Coll Cardiol; 2012 Oct; 60(16):1566-73. PubMed ID: 22999724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia.
    McNair WP; Ku L; Taylor MR; Fain PR; Dao D; Wolfel E; Mestroni L;
    Circulation; 2004 Oct; 110(15):2163-7. PubMed ID: 15466643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiogram changes and atrial arrhythmias in individuals carrying sodium channel SCN5A D1275N mutation.
    Vanninen SUM; Nikus K; Aalto-Setälä K
    Ann Med; 2017 Sep; 49(6):496-503. PubMed ID: 28294644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro.
    Watanabe H; Yang T; Stroud DM; Lowe JS; Harris L; Atack TC; Wang DW; Hipkens SB; Leake B; Hall L; Kupershmidt S; Chopra N; Magnuson MA; Tanabe N; Knollmann BC; George AL; Roden DM
    Circulation; 2011 Aug; 124(9):1001-11. PubMed ID: 21824921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and effective response of the R222Q SCN5A to quinidine treatment in a patient with Purkinje-related ventricular arrhythmia and familial dilated cardiomyopathy: a case report.
    Zakrzewska-Koperska J; Franaszczyk M; Bilińska Z; Truszkowska G; Karczmarz M; Szumowski Ł; Zieliński T; Płoski R; Bilińska M
    BMC Med Genet; 2018 Jun; 19(1):94. PubMed ID: 29871609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of
    Sedaghat-Hamedani F; Rebs S; El-Battrawy I; Chasan S; Krause T; Haas J; Zhong R; Liao Z; Xu Q; Zhou X; Akin I; Zitron E; Frey N; Streckfuss-Bömeke K; Kayvanpour E
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dilated cardiomyopathy caused by p.E446K mutation in SCN5A gene].
    Zakliaz'minskaia EV; Chapurnykh AV; Voronina TS; Van EIu; Shestak AG; Saber S; Dzemeshkevich SL
    Kardiologiia; 2014; 54(3):92-6. PubMed ID: 25102755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characterisation of a novel
    Kean AC; Helm BM; Vatta M; Ayers MD; Parent JJ; Darragh RK
    Cardiol Young; 2019 Oct; 29(10):1257-1263. PubMed ID: 31477192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del.
    Cheng J; Morales A; Siegfried JD; Li D; Norton N; Song J; Gonzalez-Quintana J; Makielski JC; Hershberger RE
    Clin Transl Sci; 2010 Dec; 3(6):287-94. PubMed ID: 21167004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A leaky voltage sensor domain of cardiac sodium channels causes arrhythmias associated with dilated cardiomyopathy.
    Moreau A; Gosselin-Badaroudine P; Mercier A; Burger B; Keller DI; Chahine M
    Sci Rep; 2018 Sep; 8(1):13804. PubMed ID: 30218094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.
    Neu A; Eiselt M; Paul M; Sauter K; Stallmeyer B; Isbrandt D; Schulze-Bahr E
    Hum Mutat; 2010 Aug; 31(8):E1609-21. PubMed ID: 20564468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifocal ectopic Purkinje-related premature contractions: a new SCN5A-related cardiac channelopathy.
    Laurent G; Saal S; Amarouch MY; Béziau DM; Marsman RF; Faivre L; Barc J; Dina C; Bertaux G; Barthez O; Thauvin-Robinet C; Charron P; Fressart V; Maltret A; Villain E; Baron E; Mérot J; Turpault R; Coudière Y; Charpentier F; Schott JJ; Loussouarn G; Wilde AA; Wolf JE; Baró I; Kyndt F; Probst V
    J Am Coll Cardiol; 2012 Jul; 60(2):144-56. PubMed ID: 22766342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transgenic zebrafish model of a human cardiac sodium channel mutation exhibits bradycardia, conduction-system abnormalities and early death.
    Huttner IG; Trivedi G; Jacoby A; Mann SA; Vandenberg JI; Fatkin D
    J Mol Cell Cardiol; 2013 Aug; 61():123-32. PubMed ID: 23791817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal atrial and ventricular premature contractions with an increased risk of dilated cardiomyopathy caused by a Na
    Calloe K; Broendberg AK; Christensen AH; Pedersen LN; Olesen MS; de Los Angeles Tejada M; Friis S; Thomsen MB; Bundgaard H; Jensen HK
    Int J Cardiol; 2018 Apr; 257():160-167. PubMed ID: 29506689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system.
    Bezzina CR; Rook MB; Groenewegen WA; Herfst LJ; van der Wal AC; Lam J; Jongsma HJ; Wilde AA; Mannens MM
    Circ Res; 2003 Feb; 92(2):159-68. PubMed ID: 12574143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia.
    Tan BH; Iturralde-Torres P; Medeiros-Domingo A; Nava S; Tester DJ; Valdivia CR; Tusié-Luna T; Ackerman MJ; Makielski JC
    Cardiovasc Res; 2007 Dec; 76(3):409-17. PubMed ID: 17897635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.